Journal
NEUROLOGY
Volume 78, Issue 13, Pages 1016-1024Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31824d58ab
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research
- Volkswagen Foundation
- Hermann and Lilly Schilling Foundation
- Merck Serono
- National Parkinson Foundation
- Parkinson Study Group
- Parkinson Disease Foundation
- Michael J Fox Foundation
- German research foundation
- Bachmann-Strauss dystonia
- Parkinson foundation
- Dystonia Medical Research Foundation
- Ontario Problem Gambling Research Centre
- German Research Foundation (DFG)
- University of Lubeck
- Possehl Foundation
- Fritz Thyssen Foundation
Ask authors/readers for more resources
Originally, locus symbols (e.g., DYT1) were introduced to specify chromosomal regions that had been linked to a familial disorder with a yet unknown gene. Symbols were systematically assigned in a numerical series to designate mapped loci for a specific phenotype or group of phenotypes. Since the system of designating and using locus symbols was originally established, both our knowledge and our techniques of gene discovery have evolved substantially. The current system has problems that are sources of confusion, perpetuate misinformation, and misrepresent the system as a useful reference tool for a list of inherited disorders of a particular phenotypic class. These include erroneously assigned loci, duplicated loci, missing symbols, missing loci, unconfirmed loci in a consecutively numbered system, combining causative genes and risk factor genes in the same list, and discordance between phenotype and list assignment. In this article, we describe these problems and their impact, and propose solutions. The system could be significantly improved by creating distinct lists for clinical and research purposes, creating more informative locus symbols, distinguishing disease-causing mutations from risk factors, raising the threshold of evidence prior to assigning a locus symbol, paying strict attention to the predominant phenotype when assigning symbols lists, and having a formal system for reviewing and continually revising the list that includes input from both clinical and genetics experts. Neurology (R) 2012;78:1016-1024
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available